SPECIFIC-INHIBITION OF MACROPHAGE-MIGRATION INHIBITION-FACTOR BY FUCOSYLATED GLYCOLIPID RM

被引:13
作者
MIURA, T [1 ]
HANDA, S [1 ]
YAMAKAWA, T [1 ]
机构
[1] UNIV TOKYO,FAC MED,DEPT BIOCHEM,TOKYO 113,JAPAN
关键词
D O I
10.1093/oxfordjournals.jbchem.a132583
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of glycolipids on the interaction of the MIF (migration inhibition factor) with rat macrophages were examined using a migration inhibition assay system. MIF activity was specifically blocked by fucosylated Glycolipid RM [Galα1-3Gal(2-lαFuc)β1-3GalNAcβ1-3Galβ1-4Glcβ1-1ceramide, (1978) J. Biochem. 83, 85-90], but not by Cytolipin R, hematoside, or blood group B active glycolipid [Galα1-3Gal(2-1αFuc)β1-4GlcNAcβ1-3Galβ1-4Glcβ1-1ceramide]. Inhibition of MIF activity was proportional to the concentration of Glycolipid RM. These findings suggest that Glycolipid RM acts as a receptor for MIF. © 1979 by The Journal of Biochemistry.
引用
收藏
页码:773 / 776
页数:4
相关论文
共 16 条
[1]  
ANDO S, 1973, J BIOCHEM-TOKYO, V73, P387
[2]  
BOYUM A, 1968, SCAND J CLIN LAB S97, V21, P1
[3]   CELLULAR HYPERSENSITIVITY AND IMMUNITY - INHIBITION OF MACROPHAGE MIGRATION AND LYMPHOCYTE MEDIATORS [J].
DAVID, JR ;
DAVID, RR .
PROGRESS IN ALLERGY, 1972, 16 :300-+
[4]   PRODUCTION OF MIGRATION-INHIBITION FACTOR (MIF) BY HUMAN ESTABLISHED B-TYPE CELL LINES DERIVED FROM NORMAL AND MALIGNANT TISSUES - STUDIES OF SOME FACTORS AFFECTING MIF RELEASE [J].
FLORENTIN, I ;
BRULEY, M ;
BELPOMME, D .
CELLULAR IMMUNOLOGY, 1975, 17 (01) :285-294
[5]  
FOX RA, 1974, J IMMUNOL, V112, P1867
[6]   CHARACTERIZATION OF GLYCOLIPIDS FROM RAT GRANULOMA AND MACROPHAGE [J].
HANADA, E ;
HANDA, S ;
KONNO, K ;
YAMAKAWA, T .
JOURNAL OF BIOCHEMISTRY, 1978, 83 (01) :85-90
[7]   GLYCOLIPIDS IN GRANULOMAS DURING GROWTH [J].
HANADA, E ;
KONNO, K ;
HANDA, S ;
YAMAKAWA, T .
JOURNAL OF BIOCHEMISTRY, 1977, 81 (04) :1079-1083
[8]   MACROPHAGE-MIGRATION FROM AN AGAROSE DROPLET - MICROMETHOD FOR ASSAY OF DELAYED-HYPERSENSITIVITY IN MOUSE [J].
HARRINGTON, JT .
CELLULAR IMMUNOLOGY, 1974, 12 (03) :476-480
[9]  
HARRINGTON JT, 1973, J IMMUNOL, V110, P752
[10]  
HIGGINS TJ, 1978, J IMMUNOL, V121, P880